scispace - formally typeset
W

William Borkowsky

Researcher at New York University

Publications -  215
Citations -  10325

William Borkowsky is an academic researcher from New York University. The author has contributed to research in topics: Viral load & Vaccination. The author has an hindex of 51, co-authored 214 publications receiving 9992 citations. Previous affiliations of William Borkowsky include Cornell University & State University of New York Upstate Medical University.

Papers
More filters
Journal ArticleDOI

Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines.

TL;DR: A reliable, high-throughput technique that requires minimal sample volume to measure multiple antibody concentrations concurrently, and is an efficient alternative to ELISAs for the measurement of vaccine-elicited antibody responses in large cohorts is developed.
Journal ArticleDOI

Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants.

TL;DR: A higher proportion of positive metabolic screens in HIV screen–positive neonates suggests that HIV or ARV exposure is associated with dysfunctional intermediary metabolism in newborns, suggesting that ARV may perturb normal fatty acid oxidation in some infants.
Journal Article

The Proliferative Response of Human Lymphocytes to Antigen Is Suppressed Preferentially by Lymphocytes Precultured with the same Antigen

TL;DR: Human blood lymphocytes activated in vitro with antigen to which the donor is reactive are capable of suppressing the secondary proliferative response of autochthonous fresh cells to antigen, both antigen-specific and antigen-nonspecific suppression.
Journal ArticleDOI

HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.

TL;DR: Differences in PD-1+ CD4 T-cell memory phenotype and response to blockade between HIV-infected children and adults are highlighted, with implications for potential immune checkpoint therapies.